Vor Biopharma Inc (NAS:VOR)
$ 1.72 -0.02 (-1.15%) Market Cap: 117.41 Mil Enterprise Value: 46.03 Mil PE Ratio: 0 PB Ratio: 0.96 GF Score: 36/100

Vor Biopharma Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 08:50PM GMT
Release Date Price: $5.1 (-0.97%)
Albert Wong
Morgan Stanley - Analyst

I'm Albert Wong from Morgan Stanley here with Nate Jorgensen from Vor, and I will be moderating this fireside chat. Thank you for all being here.

For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales rep. Thank you for listening to that.

Nate, maybe you can just quickly introduce yourself to the new people to the Vor story and then we can get started.

Nate Jorgensen
Vor Biopharma, Inc. - CFO

All right. Thanks, Albert. Well, thank you for having us here at the Morgan Stanley Health Care Conference. My name is Nathan Jorgensen. I'm the CFO at Vor. I've been at Vor two years. Prior to that I've (inaudible) on the investment side and then decided to take an operational role.

Questions & Answers

Albert Wong
Morgan Stanley - Analyst

Okay, great. Maybe to kick off, you can walk us through at a high level, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot